<DOC>
	<DOC>NCT00778622</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of the baseline body mass index (BMI) on the response to Glucophage XR monotherapy in glycemic control in Chinese patients with newly diagnosed type 2 diabetes</brief_summary>
	<brief_title>Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Signed Written Informed Consent Age≥ 17 and &lt;80 years, Newly diagnosed T2DM (defined as T2DM diagnosed within 6 months prior to enrollment) Oral antidiabetic agents naïve (defined as without receiving any antidiabetic medication therapy before, or having received antidiabetic medication ≤ 14 days but not received any antidiabetic medication within the last 1 month prior to enrollment) HbA1c ≥ 7.0% and ≤10.0% Women of child bearing potential body mass index (BMI)≥35 Kg/m2 or BMI &lt;18.5 Kg/m2 Hemoglobin A1c (HbA1c)&gt;10.0% or &lt;7.0% Active liver disease and/or significant abnormal liver function Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma Congestive heart failure defined as New York Heart Association (NYHA) class III or IV and /or left ventricular ejection fraction ≤40% Significant cardiovascular history with the past 6 months Severe retinopathy, persistent uncontrolled hypertension (SBP≥180mmHg, or DBP≥105mmHg) Severe chronic gastrointestinal disease History of alcohol abuse or illegal drug abuse within the past 12 months Diagnosed anemia Creatine kinase ≥3 X ULN Serum creatinine ≥1.5 mg/dL(133μmol/L) [males], ≥1.4 mg/dL(124 μmol/L)[females] Alanine amino transferase (ALT) and/or aspartate amino transferase (AST)&gt; 1.5 X ULN and/or total bilirubin &gt; 2 X ULN Hemoglobin &lt;12g/dL [males], &lt;11g/dL [females] Allergies and Adverse Drug Reactions Prohibited Treatments and/or Therapies Prisoners or subjects who are involuntarily incarcerated Subjects who are compulsorily detained for treatment of either a psychiatric or physical (eg, infectious disease) illness Subjects decline to participate</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>